Monitor the outcome of the December 3, 2026 special meeting vote. If approved, watch for subsequent Board action on the reverse split ratio and timing, which could affect share price and liquidity. No immediate catalyst.
Price Chart
Executive Summary
Traws Pharma filed a DEFA14A (definitive additional proxy soliciting material) to provide a notice of internet availability of proxy materials for a special special meeting scheduled for December 3, 2026. The sole substantive proposal is to grant the Board discretionary authority to effect a reverse stock split at a ratio between 1-for-8 and 1-for-15, to be determined by the Board within 12 months of stockholder approval. This is a routine capital structure management filing, not a contested matter or activist campaign.
Key Financial Metrics
Key Facts
- Special Meeting of Stockholders scheduled for December 3, 2026 at 9:00 AM ET, held virtually
- Proposal 1: Grant Board discretionary authority to amend certificate of incorporation to effect a reverse stock split at a ratio between 1-for-8 and 1-for-15
- Proposal 2: Approve adjournment of the Special Meeting to solicit additional proxies if needed
- Record date for stockholders of October 6, 2026 are entitled to vote
- Board recommends a vote FOR both proposals
- Filed by the Registrant (management) — not a dissident or activist
Financial Impact
No financial figures disclosed in this filing. Reverse stock split ratio range (1-for-8 to 1-for-15) authorized but not yet executed.
Risk Factors
- Reverse stock split could signal low share price and potential delisting risk if not executed in time
- Shareholder approval is required — failure to pass could limit the company's ability to maintain listing standards
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-117414 |
| Document: 0001104659-26-117414-index-headers.html | 0001104659-26-117414 |
| Document: 0001104659-26-117414-index.html | 0001104659-26-117414 |
| Document: 0001104659-26-117414.txt | 0001104659-26-117414 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | — | awaiting T+20 | — | — |
Oct 23, 2026 3d ago | 8-K | $0.3510 | awaiting T+20 | — | $0.3400 (+3.13%) |
Oct 20, 2026 6d ago | DEFA14A | $0.3760 | awaiting T+20 | — | $0.3400 (−9.57%) |
Oct 20, 2026 6d ago | DEF 14A | $0.3760 | awaiting T+20 | — | $0.3400 (+9.57%) |
Aug 14, 2026 10w ago | Press Release | $0.5400 $0.5200 | ▲ +3.70% | ▲ +2.18% | $0.3400 (+37.04%) |
Jul 10, 2026 15w ago | 8-K | $0.6849 $0.5400 | ▲ +21.16% | ▲ +24.34% | $0.3400 (+50.36%) |
Jul 10, 2026 15w ago | 424B5 | $0.6849 $0.5400 | ▲ +21.16% | ▲ +24.34% | $0.3400 (+50.36%) |
Jul 10, 2026 15w ago | EFFECT | $0.7600 $0.5320 | ▲ +30.00% | ▲ +32.43% | $0.3400 (+55.26%) |
Jul 9, 2026 15w ago | 8-K | $0.7600 $0.5320 | ▼ −30.00% | ▼ −32.43% | $0.3400 (−55.26%) |
Jul 1, 2026 16w ago | S-3 | $0.7677 $0.4411 | ▼ −42.54% | ▼ −42.13% | $0.3400 (−55.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers